These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

670 related articles for article (PubMed ID: 33946488)

  • 41. Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease.
    Bonfili L; Cecarini V; Gogoi O; Gong C; Cuccioloni M; Angeletti M; Rossi G; Eleuteri AM
    FEBS J; 2021 May; 288(9):2836-2855. PubMed ID: 32969566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The gut microbiota-brain axis, psychobiotics and its influence on brain and behaviour: A systematic review.
    Barrio C; Arias-Sánchez S; Martín-Monzón I
    Psychoneuroendocrinology; 2022 Mar; 137():105640. PubMed ID: 34942539
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.
    Wang Y; Dykes GA
    CNS Neurol Disord Drug Targets; 2022; 21(1):14-25. PubMed ID: 34365962
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of chronic noise exposure on the microbiome-gut-brain axis in senescence-accelerated prone mice: implications for Alzheimer's disease.
    Cui B; Su D; Li W; She X; Zhang M; Wang R; Zhai Q
    J Neuroinflammation; 2018 Jun; 15(1):190. PubMed ID: 29933742
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Brain-Gut-Microbiota Axis in Alzheimer's Disease.
    Kowalski K; Mulak A
    J Neurogastroenterol Motil; 2019 Jan; 25(1):48-60. PubMed ID: 30646475
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Gut Microbiome and Alzheimer's Disease: A Growing Relationship.
    Bou Zerdan M; Hebbo E; Hijazi A; El Gemayel M; Nasr J; Nasr D; Yaghi M; Bouferraa Y; Nagarajan A
    Curr Alzheimer Res; 2022; 19(12):808-818. PubMed ID: 36578263
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Emerging role of gut microbiota dysbiosis in neuroinflammation and neurodegeneration.
    Solanki R; Karande A; Ranganathan P
    Front Neurol; 2023; 14():1149618. PubMed ID: 37255721
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The Gut Microbiome Alterations and Inflammation-Driven Pathogenesis of Alzheimer's Disease-a Critical Review.
    Sochocka M; Donskow-Łysoniewska K; Diniz BS; Kurpas D; Brzozowska E; Leszek J
    Mol Neurobiol; 2019 Mar; 56(3):1841-1851. PubMed ID: 29936690
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A State-of-Art Review of the Vicious Circle of Sleep Disorders, Diabetes and Neurodegeneration Involving Metabolism and Microbiota Alterations.
    Versace S; Pellitteri G; Sperotto R; Tartaglia S; Da Porto A; Catena C; Gigli GL; Cavarape A; Valente M
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445790
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles and Mechanisms of Gut Microbiota in Patients With Alzheimer's Disease.
    Wu S; Liu X; Jiang R; Yan X; Ling Z
    Front Aging Neurosci; 2021; 13():650047. PubMed ID: 34122039
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stressed mitochondria: A target to intrude alzheimer's disease.
    Sharma VK; Singh TG; Mehta V
    Mitochondrion; 2021 Jul; 59():48-57. PubMed ID: 33839319
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prenatal noise stress aggravates cognitive decline and the onset and progression of beta amyloid pathology in a mouse model of Alzheimer's disease.
    Jafari Z; Okuma M; Karem H; Mehla J; Kolb BE; Mohajerani MH
    Neurobiol Aging; 2019 May; 77():66-86. PubMed ID: 30784814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Dysbiosis and Alzheimer's Disease: Cause or Treatment Opportunity?
    Janeiro MH; Ramírez MJ; Solas M
    Cell Mol Neurobiol; 2022 Mar; 42(2):377-387. PubMed ID: 33400081
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanistic Insights Into Gut Microbiome Dysbiosis-Mediated Neuroimmune Dysregulation and Protein Misfolding and Clearance in the Pathogenesis of Chronic Neurodegenerative Disorders.
    Padhi P; Worth C; Zenitsky G; Jin H; Sambamurti K; Anantharam V; Kanthasamy A; Kanthasamy AG
    Front Neurosci; 2022; 16():836605. PubMed ID: 35281490
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mind-altering with the gut: Modulation of the gut-brain axis with probiotics.
    Kim N; Yun M; Oh YJ; Choi HJ
    J Microbiol; 2018 Mar; 56(3):172-182. PubMed ID: 29492874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration.
    Lazar E; Sherzai A; Adeghate J; Sherzai D
    Front Biosci (Schol Ed); 2021 Jun; 13(1):17-29. PubMed ID: 34256527
    [TBL] [Abstract][Full Text] [Related]  

  • 57. From Microbes to Memories: Challenges and Future Perspectives Regarding the Gut-Brain Axis for Improved Cognitive Health in Alzheimer's.
    Franco CD; Sagar RS; Bokhari SFH
    Cureus; 2024 Jan; 16(1):e52795. PubMed ID: 38389631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 27-Hydroxycholesterol contributes to cognitive deficits in APP/PS1 transgenic mice through microbiota dysbiosis and intestinal barrier dysfunction.
    Wang Y; An Y; Ma W; Yu H; Lu Y; Zhang X; Wang Y; Liu W; Wang T; Xiao R
    J Neuroinflammation; 2020 Jun; 17(1):199. PubMed ID: 32593306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The brain-gut-microbiota axis in the treatment of neurologic and psychiatric disorders.
    Naufel MF; Truzzi GM; Ferreira CM; Coelho FMS
    Arq Neuropsiquiatr; 2023 Jul; 81(7):670-684. PubMed ID: 37402401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mild cognitive impairment has similar alterations as Alzheimer's disease in gut microbiota.
    Li B; He Y; Ma J; Huang P; Du J; Cao L; Wang Y; Xiao Q; Tang H; Chen S
    Alzheimers Dement; 2019 Oct; 15(10):1357-1366. PubMed ID: 31434623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.